期刊文献+

左、右半结肠癌基因表达差异及相关药物治疗现状 被引量:2

The different status of gene expression and relevant drug treatment of left and right colon cancer
下载PDF
导出
摘要 回顾近年来最新有关左、右半结肠癌之间的基因类型表达差异性的研究,结合左、右半结肠癌对抗癌药物的敏感性差异的相关报道,进一步总结左、右半结肠癌基因表达与药物治疗的关系,为指导临床医师合理选择针对结肠不同原发部位的抗癌药物和新型抗癌药的开发提供依据。 By reviewing the recent research progresses about different expression of gene types between left and right colon cancer, and combining some studies about different sensibility of anticarcinogen to left and right colon cancer, the relativity between gene expression and medication was clarified to provide a theoretical evidence for choice of drugs and development of new drugs for colon cancer of different primary sites.
出处 《胃肠病学和肝病学杂志》 CAS 2017年第8期841-844,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 结肠癌 基因表达 辅助化疗 靶向治疗 Colon cancer Gene expression Adjuvant chemotherapy Targeted therapy
  • 相关文献

参考文献2

二级参考文献78

  • 1Heavey PM, McKenna D, Rowland IR. Colorectal cancerand the relationship between genes and the environment. NutrCancer 2004; 48: 124-141 [PMID: 15231447 DOI: 10.1207/s15327914nc4802_2].
  • 2Terzi-J, Grivennikov S, Karin E, Karin M. Inflammation andcolon cancer. Gastroenterology 2010; 138: 2101-2114.e5 [PMID:20420949 DOI: 10.1053/j.gastro.2010.01.058].
  • 3Schetter AJ, Harris CC. Alterations of microRNAs contribute tocolon carcinogenesis. Semin Oncol 2011; 38: 734-742 [PMID:22082759 DOI: 10.1053/j.seminoncol.2011.08.009].
  • 4Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E,Norat T. Red and processed meat and colorectal cancer incidence:meta-analysis of prospective studies. PLoS One 2011; 6: e20456[PMID: 21674008 DOI: 10.1371/journal.pone.0020456].
  • 5Doubeni CA, Laiyemo AO, Major JM, Schootman M, Lian M,Park Y, Graubard BI, Hollenbeck AR, Sinha R. Socioeconomicstatus and the risk of colorectal cancer: an analysis of more than ahalf million adults in the National Institutes of Health-AARP Dietand Health Study. Cancer 2012; 118: 3636-3644 [PMID: 22898918DOI: 10.1002/cncr.26677].
  • 6Hravec S, Glava-D. MicroRNAs as Novel Biomarkers inColorectal Cancer. Front Genet 2012; 3: 180 [PMID: 23091478].
  • 7American Cancer Society. Colorectal Cancer Facts & Figures2011-2013. Atlanta: American Cancer Society, 2011. Availablefrom: URL: http://www.cancer.org/research/cancerfactsfigures/colorectalcancerfactsfigures/colorectal-cancer-facts-figures-2011-2013-page.
  • 8American Cancer Society. Cancer Facts & Figures 2012. Atlanta:American Cancer Society; 2012. Available from: URL: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/.
  • 9Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, PanJ, Galandiuk S. Plasma miR-21: a potential diagnostic marker ofcolorectal cancer. Ann Surg 2012; 256: 544-551 [PMID: 22868372DOI: 10.1097/SLA.0b013e318265bd6f].
  • 10American Cancer Society. Cancer Facts and Figures, 2010.American Cancer Society. Accessed April 13, 2014. Availablefrom: URL: http://www.cancer.org/Research/CancerFactsFigures/index.

共引文献45

同被引文献18

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部